1
|
Yang X, Feng B, Yang H, Wang X, Luo H, Chen L, Jin F, Wang Y. CNN-based multi-modal radiomics analysis of pseudo-CT utilization in MRI-only brain stereotactic radiotherapy: a feasibility study. BMC Cancer 2024; 24:59. [PMID: 38200424 PMCID: PMC10782704 DOI: 10.1186/s12885-024-11844-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Accepted: 01/04/2024] [Indexed: 01/12/2024] Open
Abstract
BACKGROUND Pseudo-computed tomography (pCT) quality is a crucial issue in magnetic resonance image (MRI)-only brain stereotactic radiotherapy (SRT), so this study systematically evaluated it from the multi-modal radiomics perspective. METHODS 34 cases (< 30 cm³) were retrospectively included (2021.9-2022.10). For each case, both CT and MRI scans were performed at simulation, and pCT was generated by a convolutional neural network (CNN) from planning MRI. Conformal arc or volumetric modulated arc technique was used to optimize the dose distribution. The SRT dose was compared between pCT and planning CT with dose volume histogram (DVH) metrics and gamma index. Wilcoxon test and Spearman analysis were used to identify key factors associated with dose deviations. Additionally, original image features were extracted for radiomic analysis. Tumor control probability (TCP) and normal tissue complication probability (NTCP) were employed for efficacy evaluation. RESULTS There was no significant difference between pCT and planning CT except for radiomics. The mean value of Hounsfield unit of the planning CT was slightly higher than that of pCT. The Gadolinium-based agents in planning MRI could increase DVH metrics deviation slightly. The median local gamma passing rates (1%/1 mm) between planning CTs and pCTs (non-contrast) was 92.6% (range 63.5-99.6%). Also, differences were observed in more than 85% of original radiomic features. The mean absolute deviation in TCP was 0.03%, and the NTCP difference was below 0.02%, except for the normal brain, which had a 0.16% difference. In addition, the number of SRT fractions and lesions, and lesion morphology could influence dose deviation. CONCLUSIONS This is the first multi-modal radiomics analysis of CNN-based pCT from planning MRI for SRT of small brain lesions, covering dosiomics and radiomics. The findings suggest the potential of pCT in SRT plan design and efficacy prediction, but caution needs to be taken for radiomic analysis.
Collapse
Affiliation(s)
- Xin Yang
- Departments of Radiation Oncology, Chongqing University Cancer Hospital, No. 181, Han Yu Road, Shapingba District, Chongqing, 400030, People's Republic of China.
| | - Bin Feng
- Departments of Radiation Oncology, Chongqing University Cancer Hospital, No. 181, Han Yu Road, Shapingba District, Chongqing, 400030, People's Republic of China
| | - Han Yang
- Departments of Radiation Oncology, Chongqing University Cancer Hospital, No. 181, Han Yu Road, Shapingba District, Chongqing, 400030, People's Republic of China
| | - Xiaoqi Wang
- Apodibot Medical, Beijing, People's Republic of China
| | - Huanli Luo
- Departments of Radiation Oncology, Chongqing University Cancer Hospital, No. 181, Han Yu Road, Shapingba District, Chongqing, 400030, People's Republic of China
| | - Liyuan Chen
- Departments of Radiation Oncology, Chongqing University Cancer Hospital, No. 181, Han Yu Road, Shapingba District, Chongqing, 400030, People's Republic of China
| | - Fu Jin
- Departments of Radiation Oncology, Chongqing University Cancer Hospital, No. 181, Han Yu Road, Shapingba District, Chongqing, 400030, People's Republic of China.
| | - Ying Wang
- Departments of Radiation Oncology, Chongqing University Cancer Hospital, No. 181, Han Yu Road, Shapingba District, Chongqing, 400030, People's Republic of China.
| |
Collapse
|
2
|
Sadeghi S, Siavashpour Z, Vafaei Sadr A, Farzin M, Sharp R, Gholami S. A rapid review of influential factors and appraised solutions on organ delineation uncertainties reduction in radiotherapy. Biomed Phys Eng Express 2021; 7. [PMID: 34265746 DOI: 10.1088/2057-1976/ac14d0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2021] [Accepted: 07/15/2021] [Indexed: 11/11/2022]
Abstract
Background and purpose.Accurate volume delineation plays an essential role in radiotherapy. Contouring is a potential source of uncertainties in radiotherapy treatment planning that could affect treatment outcomes. Therefore, reducing the degree of contouring uncertainties is crucial. The role of utilized imaging modality in the organ delineation uncertainties has been investigated. This systematic review explores the influential factors on inter-and intra-observer uncertainties of target volume and organs at risk (OARs) delineation focusing on the used imaging modality for these uncertainties reduction and the reported subsequent histopathology and follow-up assessment.Methods and materials.An inclusive search strategy has been conducted to query the available online databases (Scopus, Google Scholar, PubMed, and Medline). 'Organ at risk', 'target', 'delineation', 'uncertainties', 'radiotherapy' and their relevant terms were utilized using every database searching syntax. Final article extraction was performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. Included studies were limited to the ones published in English between 1995 and 2020 and that just deal with computed tomography (CT) and magnetic resonance imaging (MRI) modalities.Results.A total of 923 studies were screened and 78 were included of which 31 related to the prostate 20 to the breast, 18 to the head and neck, and 9 to the brain tumor site. 98% of the extracted studies performed volumetric analysis. Only 24% of the publications reported the dose deviations resulted from variation in volume delineation Also, heterogeneity in studied populations and reported geometric and volumetric parameters were identified such that quantitative synthesis was not appropriate.Conclusion.This review highlightes the inter- and intra-observer variations that could lead to contouring uncertainties and impede tumor control in radiotherapy. For improving volume delineation and reducing inter-observer variability, the implementation of well structured training programs, homogeneity in following consensus and guidelines, reliable ground truth selection, and proper imaging modality utilization could be clinically beneficial.
Collapse
Affiliation(s)
- Sogand Sadeghi
- Department of Nuclear Physics, Faculty of Sciences, University of Mazandaran, Babolsar, Iran
| | - Zahra Siavashpour
- Department of Radiation Oncology, Shohada-e Tajrish Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Alireza Vafaei Sadr
- Département de Physique Théorique and Center for Astroparticle Physics, Université de Genève, Geneva, Switzerland
| | - Mostafa Farzin
- Radiation Oncology Research Center (RORC), Tehran University of Medical Science, Tehran, Iran.,Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
| | - Ryan Sharp
- Department of Health Physics and Diagnostic Sciences, University of Nevada, Las Vegas, NV, United States of America
| | - Somayeh Gholami
- Radiotherapy Oncology Department, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
3
|
Liu X, Emami H, Nejad‐Davarani SP, Morris E, Schultz L, Dong M, K. Glide‐Hurst C. Performance of deep learning synthetic CTs for MR-only brain radiation therapy. J Appl Clin Med Phys 2021; 22:308-317. [PMID: 33410568 PMCID: PMC7856502 DOI: 10.1002/acm2.13139] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2020] [Revised: 12/02/2020] [Accepted: 12/03/2020] [Indexed: 12/31/2022] Open
Abstract
PURPOSE To evaluate the dosimetric and image-guided radiation therapy (IGRT) performance of a novel generative adversarial network (GAN) generated synthetic CT (synCT) in the brain and compare its performance for clinical use including conventional brain radiotherapy, cranial stereotactic radiosurgery (SRS), planar, and volumetric IGRT. METHODS AND MATERIALS SynCT images for 12 brain cancer patients (6 SRS, 6 conventional) were generated from T1-weighted postgadolinium magnetic resonance (MR) images by applying a GAN model with a residual network (ResNet) generator and a convolutional neural network (CNN) with 5 convolutional layers as the discriminator that classified input images as real or synthetic. Following rigid registration, clinical structures and treatment plans derived from simulation CT (simCT) images were transferred to synCTs. Dose was recalculated for 15 simCT/synCT plan pairs using fixed monitor units. Two-dimensional (2D) gamma analysis (2%/2 mm, 1%/1 mm) was performed to compare dose distributions at isocenter. Dose-volume histogram (DVH) metrics (D95% , D99% , D0.2cc, and D0.035cc ) were assessed for the targets and organ at risks (OARs). IGRT performance was evaluated via volumetric registration between cone beam CT (CBCT) to synCT/simCT and planar registration between KV images to synCT/simCT digital reconstructed radiographs (DRRs). RESULTS Average gamma passing rates at 1%/1mm and 2%/2mm were 99.0 ± 1.5% and 99.9 ± 0.2%, respectively. Excellent agreement in DVH metrics was observed (mean difference ≤0.10 ± 0.04 Gy for targets, 0.13 ± 0.04 Gy for OARs). The population averaged mean difference in CBCT-synCT registrations were <0.2 mm and 0.1 degree different from simCT-based registrations. The mean difference between kV-synCT DRR and kV-simCT DRR registrations was <0.5 mm with no statistically significant differences observed (P > 0.05). An outlier with a large resection cavity exhibited the worst-case scenario. CONCLUSION Brain GAN synCTs demonstrated excellent performance for dosimetric and IGRT endpoints, offering potential use in high precision brain cancer therapy.
Collapse
Affiliation(s)
- Xiaoning Liu
- Department of Medical PhysicsMemorial Sloan Kettering Cancer CenterMiddletownNJUSA
| | - Hajar Emami
- Department of Computer ScienceWayne State UniversityDetroitMIUSA
| | | | - Eric Morris
- Department of Radiation OncologyUniversity of California—Los AngelesLos AngelesCAUSA
| | - Lonni Schultz
- Department of Public Health SciencesHenry Ford Health SystemDetroitMIUSA
| | - Ming Dong
- Department of Computer ScienceWayne State UniversityDetroitMIUSA
| | - Carri K. Glide‐Hurst
- Department of Human OncologySchool of Medicine and Public HeathUniversity of Wisconsin – MadisonMadisonWIUSA
| |
Collapse
|
4
|
Karino T, Ohira S, Kanayama N, Wada K, Ikawa T, Nitta Y, Washio H, Miyazaki M, Teshima T. Determination of optimal virtual monochromatic energy level for target delineation of brain metastases in radiosurgery using dual-energy CT. Br J Radiol 2020; 93:20180850. [PMID: 31825643 DOI: 10.1259/bjr.20180850] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
OBJECTIVE Determination of the optimal energy level of virtual monochromatic image (VMI) for brain metastases in contrast-enhanced dual-energy CT (DECT) for radiosurgery and assessment of the subjective and objective image quality of VMI at the optimal energy level. METHODS 20 patients (total of 42 metastases) underwent contrast-enhanced DECT. Spectral image analysis of VMIs at energy levels ranging from 40 to 140 keV in 1 keV increments was performed to determine the optimal VMI (VMIopt) as the one corresponding to the highest contrast-to-noise ratio (CNR) between brain parenchyma and the metastases. The objective and subjective values of VMIopt were compared to those of the VMI with 120 kVp equivalent, defined as reference VMI (VMIref, 77 keV). The objective measurement parameters included mean HU value and SD of tumor and brain parenchyma, absolute lesion contrast (LC), and CNR. The subjective measurements included five-point scale assessment of "overall image quality" and "tumor delineation" by three radiation oncologists. RESULTS The VMI at 63 keV was defined as VMIopt. The LC and CNR of VMIopt were significantly (p < 0.01) higher than those of VMIref (LC: 37.4 HU vs 24.7 HU; CNR: 1.1 vs 0.8, respectively). Subjective analysis rated VMIopt significantly (p < 0.01) superior to VMIref with respect to the overall image quality (3.2 vs 2.9, respectively) and tumor delineation (3.5 vs 2.9, respectively). CONCLUSION The VMI at 63 keV derived from contrast-enhanced DECT yielded the highest CNR and improved the objective and subjective image quality for radiosurgery, compared to VMIref. ADVANCES IN KNOWLEDGE This paper investigated for the first time the optimal energy level of VMI in DECT for brain metastases. The findings will lead to improvement in tumor visibility with optimal VMI and consequently supplement accuracy delineation of brain metastases.
Collapse
Affiliation(s)
- Tsukasa Karino
- Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Shingo Ohira
- Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.,Department of Medical Physics and Engineering, Osaka University Graduate of Medicine, Osaka, Japan
| | - Naoyuki Kanayama
- Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Kentaro Wada
- Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Toshiki Ikawa
- Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Yuya Nitta
- Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Hayate Washio
- Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
| | - Masayoshi Miyazaki
- Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan.,Department of Radiology, Hyogo College of Medicine, Hyogo, Japan
| | - Teruki Teshima
- Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
| |
Collapse
|
5
|
Adjeiwaah M, Garpebring A, Nyholm T. Sensitivity analysis of different quality assurance methods for magnetic resonance imaging in radiotherapy. Phys Imaging Radiat Oncol 2020; 13:21-27. [PMID: 33458303 PMCID: PMC7807625 DOI: 10.1016/j.phro.2020.03.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2019] [Revised: 02/27/2020] [Accepted: 03/02/2020] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND AND PURPOSE There are currently no standard quality assurance (QA) methods for magnetic resonance imaging (MRI) in radiotherapy (RT). This work was aimed at evaluating the ability of two QA protocols to detect common events that affect quality of MR images under RT settings. MATERIALS AND METHODS The American College of Radiology (ACR) MRI QA phantom was repeatedly scanned using a flexible coil and action limits for key image quality parameters were derived. Using an exploratory survey, issues that reduce MR image quality were identified. The most commonly occurring events were introduced as provocations to produce MR images with degraded quality. From these images, detection sensitivities of the ACR MRI QA protocol and a commercial geometric accuracy phantom were determined. RESULTS Machine-specific action limits for key image quality parameters set at mean ± 3 σ were comparable with the ACR acceptable values. For the geometric accuracy phantom, provocations from uncorrected gradient nonlinearity effects and a piece of metal in the bore of the scanner resulted in worst distortions of 22.2 mm and 3.4 mm, respectively. The ACR phantom was sensitive to uncorrected signal variations, electric interference and a piece of metal in the bore of the scanner but could not adequately detect individual coil element failures. CONCLUSIONS The ACR MRI QA phantom combined with the large field-of-view commercial geometric accuracy phantom were generally sensitive in identifying some common MR image quality issues. The two protocols when combined may provide a tool to monitor the performance of MRI systems in the radiotherapy environment.
Collapse
Affiliation(s)
- Mary Adjeiwaah
- Department of Radiation Sciences, Umeå University, Umeå, Sweden
| | | | - Tufve Nyholm
- Department of Radiation Sciences, Umeå University, Umeå, Sweden
| |
Collapse
|
6
|
Vickers AJ, Thiruthaneeswaran N, Coyle C, Manoharan P, Wylie J, Kershaw L, Choudhury A, Mcwilliam A. Does magnetic resonance imaging improve soft tissue sarcoma contouring for radiotherapy? BJR Open 2019; 1:20180022. [PMID: 33178916 PMCID: PMC7592468 DOI: 10.1259/bjro.20180022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2018] [Revised: 03/27/2019] [Accepted: 03/28/2019] [Indexed: 11/27/2022] Open
Abstract
Objective: Soft tissue sarcomas (STS) are a rare, heterogeneous tumour group. Radiotherapy improves local control. CT is used to plan radiotherapy, but has poor soft tissue definition. MRI has superior soft tissue definition. Contour variation amongst oncologists is an important factor in treatment failure. This study is the first to directly compare STS tumour contouring using CT vs MRI. Methods: Planning CT and T2 weighted MR images of eight patients with STS were distributed to four oncologists. Gross tumour volume was contoured on both imaging modalities using in-house software. Images were recontoured 6 weeks later. The mean distance to agreement (DTA), standard deviation of the DTA, dice similarity coefficient (DSC) and contour volume were calculated for each oncologist and compared to a median contour volume. Results for CT and MRI were compared using a pairwise Student's t-test. Results: When comparing MRI to CT, tumour volumes were significantly smaller, with a difference of 21.4 cm3 across all patients (p = 0.008). There was not a statistically significant difference in the mean distance to agreement or dice similarity coefficient, but the standard deviation of the DTA showed a statistically significant improvement ( p = 0.04). For intraobserver variation, there was no statistically significant improvement using MRI vs CT. Conclusion: Oncologists contour smaller tumour volumes using MRI, with reduced interobserver variation. Improving the reliability and consistency of contouring is needed for improved quality assurance. Advances in knowledge: With further experience, the use of MRI in STS radiotherapy planning may reduce variation between oncologists and contribute to improved local control and reduced treatment toxicities.
Collapse
Affiliation(s)
- Alexander John Vickers
- Department of Clinical Oncology, The Christie NHS Foundation Trust, 550 Wilmslow Road, Withington, Manchester, United Kingdom
| | | | - Catherine Coyle
- Department of Clinical Oncology, The Christie NHS Foundation Trust, 550 Wilmslow Road, Withington, Manchester, United Kingdom
| | - Prakash Manoharan
- Department of Clinical Oncology, The Christie NHS Foundation Trust, 550 Wilmslow Road, Withington, Manchester, United Kingdom
| | - James Wylie
- Department of Clinical Oncology, The Christie NHS Foundation Trust, 550 Wilmslow Road, Withington, Manchester, United Kingdom
| | | | | | | |
Collapse
|
7
|
Wee CW, An HJ, Kang HC, Kim HJ, Wu HG. Variability of Gross Tumor Volume Delineation for Stereotactic Body Radiotherapy of the Lung With Tri- 60Co Magnetic Resonance Image-Guided Radiotherapy System (ViewRay): A Comparative Study With Magnetic Resonance- and Computed Tomography-Based Target Delineation. Technol Cancer Res Treat 2018; 17:1533033818787383. [PMID: 30012039 PMCID: PMC6050807 DOI: 10.1177/1533033818787383] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Introduction: To evaluate the intra-/interobserver variability of gross target volumes between
delineation based on magnetic resonance imaging and computed tomography in patients
simulated for stereotactic body radiotherapy for primary lung cancer and lung
metastasis. Materials and Methods: Twenty-five patients (27 lesions) who underwent computed tomography and magnetic
resonance simulation with the MR-60Co system (ViewRay) were included in the
study. Gross target volumes were delineated on the magnetic resonance imaging
(GTVMR) and computed tomography (GTVCT) images by 2 radiation
oncologists (RO1 and RO2). Volumes of all contours were measured. Levels of
intraobserver (GTVMR_RO vs GTVCT_RO) and interobserver
(GTVMR_RO1 vs GTVMR_RO2; GTVCT_RO1 vs
GTVCT_RO2) agreement were evaluated using the generalized κ statistics and
the paired t test. Results: No significant volumetric difference was observed between all 4 comparisons
(GTVMR_RO1 vs GTVCT_RO1, GTVMR_RO2 vs
GTVCT_RO2, GTVMR_RO1 vs GTVMR_RO2, and
GTVCT_RO1 vs GTVCT_RO2; P > .05), with mean
volumes of GTVs ranging 5 to 6 cm3. The levels of agreement between those 4
comparisons were all substantial with mean κ values of 0.64, 0.66, 0.74, and 0.63,
respectively. However, the interobserver agreement level was significantly higher for
GTVCT compared to GTVMR (P <.001). The mean
κ values significantly increased in all 4 comparisons for tumors >5 cm3
compared to tumors ≤5 cm3 (all P < .05). Conclusion: No significant differences in volumes between magnetic resonance- and computed
tomograpghy-based Gross target volumes were found among 2 ROs. Magnetic resonance-based
GTV delineation for lung stereotactic body radiotherapy also demonstrated acceptable
interobserver agreement. Tumors >5 cm3 show higher intra-/interobserver
agreement compared to tumors <5 cm3. More experience should be accumulated
to reduce variability in magnetic resonance-based Gross target volumes delineation in
lung stereotactic body radiotherapy.
Collapse
Affiliation(s)
- Chan Woo Wee
- 1 Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea, Republic of Korea
| | - Hyun Joon An
- 1 Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea, Republic of Korea
| | - Hyun-Cheol Kang
- 1 Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea, Republic of Korea
| | - Hak Jae Kim
- 1 Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea, Republic of Korea.,Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea, Republic of Korea.,Radiation Research Institute, Medical Research Center, Seoul National University, Seoul, Korea, Republic of Korea
| | - Hong-Gyun Wu
- 1 Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea, Republic of Korea.,Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea, Republic of Korea.,Radiation Research Institute, Medical Research Center, Seoul National University, Seoul, Korea, Republic of Korea
| |
Collapse
|
8
|
Bainbridge H, Salem A, Tijssen RHN, Dubec M, Wetscherek A, Van Es C, Belderbos J, Faivre-Finn C, McDonald F. Magnetic resonance imaging in precision radiation therapy for lung cancer. Transl Lung Cancer Res 2017; 6:689-707. [PMID: 29218271 PMCID: PMC5709138 DOI: 10.21037/tlcr.2017.09.02] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2017] [Accepted: 09/08/2017] [Indexed: 12/25/2022]
Abstract
Radiotherapy remains the cornerstone of curative treatment for inoperable locally advanced lung cancer, given concomitantly with platinum-based chemotherapy. With poor overall survival, research efforts continue to explore whether integration of advanced radiation techniques will assist safe treatment intensification with the potential for improving outcomes. One advance is the integration of magnetic resonance imaging (MRI) in the treatment pathway, providing anatomical and functional information with excellent soft tissue contrast without exposure of the patient to radiation. MRI may complement or improve the diagnostic staging accuracy of F-18 fluorodeoxyglucose position emission tomography and computerized tomography imaging, particularly in assessing local tumour invasion and is also effective for identification of nodal and distant metastatic disease. Incorporating anatomical MRI sequences into lung radiotherapy treatment planning is a novel application and may improve target volume and organs at risk delineation reproducibility. Furthermore, functional MRI may facilitate dose painting for heterogeneous target volumes and prediction of normal tissue toxicity to guide adaptive strategies. MRI sequences are rapidly developing and although the issue of intra-thoracic motion has historically hindered the quality of MRI due to the effect of motion, progress is being made in this field. Four-dimensional MRI has the potential to complement or supersede 4D CT and 4D F-18-FDG PET, by providing superior spatial resolution. A number of MR-guided radiotherapy delivery units are now available, combining a radiotherapy delivery machine (linear accelerator or cobalt-60 unit) with MRI at varying magnetic field strengths. This novel hybrid technology is evolving with many technical challenges to overcome. It is anticipated that the clinical benefits of MR-guided radiotherapy will be derived from the ability to adapt treatment on the fly for each fraction and in real-time, using 'beam-on' imaging. The lung tumour site group of the Atlantic MR-Linac consortium is working to generate a challenging MR-guided adaptive workflow for multi-institution treatment intensification trials in this patient group.
Collapse
Affiliation(s)
- Hannah Bainbridge
- The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - Ahmed Salem
- The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK
| | | | - Michael Dubec
- The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK
| | - Andreas Wetscherek
- The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - Corinne Van Es
- The University Medical Center Utrecht, Utrecht, the Netherlands
| | - Jose Belderbos
- The Netherlands Cancer Institute and The Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands
| | - Corinne Faivre-Finn
- The University of Manchester and The Christie NHS Foundation Trust, Manchester, UK
| | - Fiona McDonald
- The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | | |
Collapse
|
9
|
Bainbridge HE, Menten MJ, Fast MF, Nill S, Oelfke U, McDonald F. Treating locally advanced lung cancer with a 1.5T MR-Linac - Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated radiotherapy. Radiother Oncol 2017; 125:280-285. [PMID: 28987747 PMCID: PMC5710994 DOI: 10.1016/j.radonc.2017.09.009] [Citation(s) in RCA: 47] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2017] [Revised: 08/21/2017] [Accepted: 09/09/2017] [Indexed: 12/25/2022]
Abstract
PURPOSE This study investigates the feasibility and potential benefits of radiotherapy with a 1.5T MR-Linac for locally advanced non-small cell lung cancer (LA NSCLC) patients. MATERIAL AND METHODS Ten patients with LA NSCLC were retrospectively re-planned six times: three treatment plans were created according to a protocol for conventionally fractionated radiotherapy and three treatment plans following guidelines for isotoxic target dose escalation. In each case, two plans were designed for the MR-Linac, either with standard (∼7mm) or reduced (∼3mm) planning target volume (PTV) margins, while one conventional linac plan was created with standard margins. Treatment plan quality was evaluated using dose-volume metrics or by quantifying dose escalation potential. RESULTS All generated treatment plans fulfilled their respective planning constraints. For conventionally fractionated treatments, MR-Linac plans with standard margins had slightly increased skin dose when compared to conventional linac plans. Using reduced margins alleviated this issue and decreased exposure of several other organs-at-risk (OAR). Reduced margins also enabled increased isotoxic target dose escalation. CONCLUSION It is feasible to generate treatment plans for LA NSCLC patients on a 1.5T MR-Linac. Margin reduction, facilitated by an envisioned MRI-guided workflow, enables increased OAR sparing and isotoxic target dose escalation for the respective treatment approaches.
Collapse
Affiliation(s)
- Hannah E Bainbridge
- Department of Radiotherapy at The Royal Marsden NHS Foundation Trust, United Kingdom; The Institute of Cancer Research, United Kingdom.
| | - Martin J Menten
- Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom.
| | - Martin F Fast
- Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom
| | - Simeon Nill
- Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom
| | - Uwe Oelfke
- Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom
| | - Fiona McDonald
- Department of Radiotherapy at The Royal Marsden NHS Foundation Trust, United Kingdom; The Institute of Cancer Research, United Kingdom
| |
Collapse
|
10
|
Koivula L, Kapanen M, Seppälä T, Collan J, Dowling JA, Greer PB, Gustafsson C, Gunnlaugsson A, Olsson LE, Wee L, Korhonen J. Intensity-based dual model method for generation of synthetic CT images from standard T2-weighted MR images - Generalized technique for four different MR scanners. Radiother Oncol 2017; 125:411-419. [PMID: 29097012 DOI: 10.1016/j.radonc.2017.10.011] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2017] [Revised: 10/09/2017] [Accepted: 10/10/2017] [Indexed: 11/17/2022]
Abstract
BACKGROUND AND PURPOSE Recent studies have shown that it is possible to conduct entire radiotherapy treatment planning (RTP) workflow using only MR images. This study aims to develop a generalized intensity-based method to generate synthetic CT (sCT) images from standard T2-weighted (T2w) MR images of the pelvis. MATERIALS AND METHODS This study developed a generalized dual model HU conversion method to convert standard T2w MR image intensity values to synthetic HU values, separately inside and outside of atlas-segmented bone volume contour. The method was developed and evaluated with 20 and 35 prostate cancer patients, respectively. MR images with scanning sequences in clinical use were acquired with four different MR scanners of three vendors. RESULTS For the generated synthetic CT (sCT) images of the 35 prostate patients, the mean (and maximal) HU differences in soft and bony tissue volumes were 16 ± 6 HUs (34 HUs) and -46 ± 56 HUs (181 HUs), respectively, against the true CT images. The average of the PTV mean dose difference in sCTs compared to those in true CTs was -0.6 ± 0.4% (-1.3%). CONCLUSIONS The study provides a generalized method for sCT creation from standard T2w images of the pelvis. The method produced clinically acceptable dose calculation results for all the included scanners and MR sequences.
Collapse
Affiliation(s)
- Lauri Koivula
- Department of Radiation Oncology, Cancer Center, Helsinki University Central Hospital, Finland; Department of Physics, University of Helsinki, Finland; Medical Imaging and Radiation Therapy, Kymenlaakso Central Hospital, Kymenlaakso Social and Health Services (Carea), Kotka, Finland.
| | - Mika Kapanen
- Department of Medical Physics, Medical Imaging Center, Tampere University Hospital, Finland
| | - Tiina Seppälä
- Department of Radiation Oncology, Cancer Center, Helsinki University Central Hospital, Finland
| | - Juhani Collan
- Department of Radiation Oncology, Cancer Center, Helsinki University Central Hospital, Finland
| | - Jason A Dowling
- CSIRO Health and Biosecurity, The Australian e-Health & Research Centre, Herston, Australia
| | - Peter B Greer
- School of Mathematical and Physical Sciences, The University of Newcastle, Australia; Department of Radiation Oncology, Calvary Mater Newcastle Hospital, Australia
| | - Christian Gustafsson
- Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden; Department of Medical Physics, Lund University, Malmö, Sweden
| | - Adalsteinn Gunnlaugsson
- Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
| | - Lars E Olsson
- Department of Medical Physics, Lund University, Malmö, Sweden; Department of Translational Sciences, Lund University, Skåne University Hospital, Malmö, Sweden
| | - Leonard Wee
- MAASTRO Clinic, School of Oncology and Developmental Biology, Maastricht University, The Netherlands; Department of Medical Physics, Oncology Services, Vejle Hospital, Denmark
| | - Juha Korhonen
- Department of Radiation Oncology, Cancer Center, Helsinki University Central Hospital, Finland; Medical Imaging and Radiation Therapy, Kymenlaakso Central Hospital, Kymenlaakso Social and Health Services (Carea), Kotka, Finland; Department of Radiology, Helsinki University Central Hospital, Finland; Department of Nuclear Medicine, Helsinki University Central Hospital, Finland
| |
Collapse
|
11
|
Kumar S, Rai R, Moses D, Choong C, Holloway L, Vinod SK, Liney G. MRI in radiotherapy for lung cancer: A free-breathing protocol at 3T. Pract Radiat Oncol 2017; 7:e175-e183. [DOI: 10.1016/j.prro.2016.10.008] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2016] [Revised: 09/12/2016] [Accepted: 10/14/2016] [Indexed: 01/22/2023]
|
12
|
Kulkarni BSN, Bajwa H, Chandrashekhar M, Sharma SD, Singareddy R, Gudipudi D, Ahmad S, Kumar A, Sresty NM, Raju AK. CT- and MRI-based gross target volume comparison in vestibular schwannomas. Rep Pract Oncol Radiother 2017; 22:201-208. [PMID: 28461783 PMCID: PMC5403802 DOI: 10.1016/j.rpor.2017.02.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2016] [Revised: 12/31/2016] [Accepted: 02/06/2017] [Indexed: 11/27/2022] Open
Abstract
AIM This study represents an enumeration and comparison of gross target volumes (GTV) as delineated independently on contrast-enhanced computed tomography (CT) and T1 and T2 weighted magnetic resonance imaging (MRI) in vestibular schwannomas (VS). BACKGROUND Multiple imaging in radiotherapy improves target localization. METHODS AND MATERIALS 42 patients of VS were considered for this prospective study with one patient showing bilateral tumor. The GTV was delineated separately on CT and MRI. Difference in volumes were estimated individually for all the 43 lesions and similarity was studied between CT and T1 and T2 weighted MRI. RESULTS The male to female ratio for VS was found to be 1:1.3. The tumor was right sided in 34.9% and left sided in 65.1%. Tumor volumes (TV) on CT image sets were ranging from 0.251 cc to 27.27 cc. The TV for CT, MRI T1 and T2 weighted were 5.15 ± 5.2 cc, 5.8 ± 6.23 cc, and 5.9 ± 6.13 cc, respectively. Compared to MRI, CT underestimated the volumes. The mean dice coefficient between CT versus T1 and CT versus T2 was estimated to be 68.85 ± 18.3 and 66.68 ± 20.3, respectively. The percentage of volume difference between CT and MRI (%VD: mean ± SD for T1; 28.84 ± 15.0, T2; 35.74 ± 16.3) and volume error (%VE: T1; 18.77 ± 10.1, T2; 23.17 ± 13.93) were found to be significant, taking the CT volumes as the baseline. CONCLUSIONS MRI with multiple sequences should be incorporated for tumor volume delineation and they provide a clear boundary between the tumor and normal tissue with critical structures nearby.
Collapse
Affiliation(s)
| | - Harjot Bajwa
- Basavatarakam Indo American Cancer Hospital and Research Center, Hyderabad 500035, Telangana, India
| | - Mukka Chandrashekhar
- Jawaharlal Nehru Technological University Hyderabad, Kukatpally, Hyderabad 500 085, Telangana, India
| | - Sunil Dutt Sharma
- Radiological Physics & Advisory Division, Bhabha Atomic Research Centre, CTCRS, Anushaktinagar, Mumbai 400094, India
| | - Rohith Singareddy
- Basavatarakam Indo American Cancer Hospital and Research Center, Hyderabad 500035, Telangana, India
| | - Dileep Gudipudi
- Basavatarakam Indo American Cancer Hospital and Research Center, Hyderabad 500035, Telangana, India
| | - Shabbir Ahmad
- Basavatarakam Indo American Cancer Hospital and Research Center, Hyderabad 500035, Telangana, India
| | - Alok Kumar
- Clearmedi Healthcare Pvt. Ltd., Kolkata Area, India
| | - N.V.N. Madusudan Sresty
- Basavatarakam Indo American Cancer Hospital and Research Center, Hyderabad 500035, Telangana, India
| | - Alluri Krishnam Raju
- Basavatarakam Indo American Cancer Hospital and Research Center, Hyderabad 500035, Telangana, India
| |
Collapse
|
13
|
Edmund JM, Nyholm T. A review of substitute CT generation for MRI-only radiation therapy. Radiat Oncol 2017; 12:28. [PMID: 28126030 PMCID: PMC5270229 DOI: 10.1186/s13014-016-0747-y] [Citation(s) in RCA: 236] [Impact Index Per Article: 33.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2016] [Accepted: 12/21/2016] [Indexed: 12/13/2022] Open
Abstract
Radiotherapy based on magnetic resonance imaging as the sole modality (MRI-only RT) is an area of growing scientific interest due to the increasing use of MRI for both target and normal tissue delineation and the development of MR based delivery systems. One major issue in MRI-only RT is the assignment of electron densities (ED) to MRI scans for dose calculation and a similar need for attenuation correction can be found for hybrid PET/MR systems. The ED assigned MRI scan is here named a substitute CT (sCT). In this review, we report on a collection of typical performance values for a number of main approaches encountered in the literature for sCT generation as compared to CT. A literature search in the Scopus database resulted in 254 papers which were included in this investigation. A final number of 50 contributions which fulfilled all inclusion criteria were categorized according to applied method, MRI sequence/contrast involved, number of subjects included and anatomical site investigated. The latter included brain, torso, prostate and phantoms. The contributions geometric and/or dosimetric performance metrics were also noted. The majority of studies are carried out on the brain for 5–10 patients with PET/MR applications in mind using a voxel based method. T1 weighted images are most commonly applied. The overall dosimetric agreement is in the order of 0.3–2.5%. A strict gamma criterion of 1% and 1mm has a range of passing rates from 68 to 94% while less strict criteria show pass rates > 98%. The mean absolute error (MAE) is between 80 and 200 HU for the brain and around 40 HU for the prostate. The Dice score for bone is between 0.5 and 0.95. The specificity and sensitivity is reported in the upper 80s% for both quantities and correctly classified voxels average around 84%. The review shows that a variety of promising approaches exist that seem clinical acceptable even with standard clinical MRI sequences. A consistent reference frame for method benchmarking is probably necessary to move the field further towards a widespread clinical implementation.
Collapse
Affiliation(s)
- Jens M Edmund
- Radiotherapy Research Unit, Department of Oncology, Herlev & Gentofte Hospital, Copenhagen University, Herlev, Denmark. .,Niels Bohr Institute, Copenhagen University, Copenhagen, Denmark.
| | - Tufve Nyholm
- Department of Radiation Sciences, Umeå University, Umeå, SE-901 87, Sweden.,Medical Radiation Physics, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
| |
Collapse
|
14
|
Guo L, Wang G, Feng Y, Yu T, Guo Y, Bai X, Ye Z. Diffusion and perfusion weighted magnetic resonance imaging for tumor volume definition in radiotherapy of brain tumors. Radiat Oncol 2016; 11:123. [PMID: 27655356 PMCID: PMC5031292 DOI: 10.1186/s13014-016-0702-y] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2015] [Accepted: 09/13/2016] [Indexed: 12/12/2022] Open
Abstract
Accurate target volume delineation is crucial for the radiotherapy of tumors. Diffusion and perfusion magnetic resonance imaging (MRI) can provide functional information about brain tumors, and they are able to detect tumor volume and physiological changes beyond the lesions shown on conventional MRI. This review examines recent studies that utilized diffusion and perfusion MRI for tumor volume definition in radiotherapy of brain tumors, and it presents the opportunities and challenges in the integration of multimodal functional MRI into clinical practice. The results indicate that specialized and robust post-processing algorithms and tools are needed for the precise alignment of targets on the images, and comprehensive validations with more clinical data are important for the improvement of the correlation between histopathologic results and MRI parameter images.
Collapse
Affiliation(s)
- Lu Guo
- Department of Biomedical Engineering, Tianjin University, Tianjin, 300072, China
| | - Gang Wang
- Department of Biomedical Engineering, Tianjin University, Tianjin, 300072, China
| | - Yuanming Feng
- Department of Biomedical Engineering, Tianjin University, Tianjin, 300072, China. .,Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China. .,Department of Radiation Oncology, East Carolina University, 600 Moye Blvd, Greenville, NC, 27834, USA.
| | - Tonggang Yu
- Department of Radiology, Huashan hospital, Fudan University, Shanghai, 200040, China
| | - Yu Guo
- Department of Biomedical Engineering, Tianjin University, Tianjin, 300072, China
| | - Xu Bai
- Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China
| | - Zhaoxiang Ye
- Department of Radiology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, China
| |
Collapse
|
15
|
Dirix P, Haustermans K, Vandecaveye V. The value of magnetic resonance imaging for radiotherapy planning. Semin Radiat Oncol 2015; 24:151-9. [PMID: 24931085 DOI: 10.1016/j.semradonc.2014.02.003] [Citation(s) in RCA: 104] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
The success of highly conformal radiotherapy techniques in the sparing of normal tissues or in dose escalation, or both, relies heavily on excellent imaging. Because of its superior soft tissue contrast, magnetic resonance imaging is increasingly being used in radiotherapy treatment planning. This review discusses the current clinical evidence to support the pivotal role of magnetic resonance imaging in radiation oncology.
Collapse
Affiliation(s)
- Piet Dirix
- Department of Radiation Oncology, Leuvens Kankerinstituut (LKI), University Hospitals Leuven, Leuven, Belgium; Department of Radiology, Leuvens Kankerinstituut (LKI), University Hospitals Leuven, Leuven, Belgium.
| | - Karin Haustermans
- Department of Radiation Oncology, Leuvens Kankerinstituut (LKI), University Hospitals Leuven, Leuven, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium
| | - Vincent Vandecaveye
- Department of Radiology, Leuvens Kankerinstituut (LKI), University Hospitals Leuven, Leuven, Belgium; Department of Imaging & Pathology, KU Leuven, Leuven, Belgium
| |
Collapse
|
16
|
Segmentation precision of abdominal anatomy for MRI-based radiotherapy. Med Dosim 2014; 39:212-7. [PMID: 24726701 DOI: 10.1016/j.meddos.2014.02.003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2013] [Revised: 12/20/2013] [Accepted: 02/10/2014] [Indexed: 01/24/2023]
Abstract
The limited soft tissue visualization provided by computed tomography, the standard imaging modality for radiotherapy treatment planning and daily localization, has motivated studies on the use of magnetic resonance imaging (MRI) for better characterization of treatment sites, such as the prostate and head and neck. However, no studies have been conducted on MRI-based segmentation for the abdomen, a site that could greatly benefit from enhanced soft tissue targeting. We investigated the interobserver and intraobserver precision in segmentation of abdominal organs on MR images for treatment planning and localization. Manual segmentation of 8 abdominal organs was performed by 3 independent observers on MR images acquired from 14 healthy subjects. Observers repeated segmentation 4 separate times for each image set. Interobserver and intraobserver contouring precision was assessed by computing 3-dimensional overlap (Dice coefficient [DC]) and distance to agreement (Hausdorff distance [HD]) of segmented organs. The mean and standard deviation of intraobserver and interobserver DC and HD values were DC(intraobserver) = 0.89 ± 0.12, HD(intraobserver) = 3.6mm ± 1.5, DC(interobserver) = 0.89 ± 0.15, and HD(interobserver) = 3.2mm ± 1.4. Overall, metrics indicated good interobserver/intraobserver precision (mean DC > 0.7, mean HD < 4mm). Results suggest that MRI offers good segmentation precision for abdominal sites. These findings support the utility of MRI for abdominal planning and localization, as emerging MRI technologies, techniques, and onboard imaging devices are beginning to enable MRI-based radiotherapy.
Collapse
|
17
|
Korsholm ME, Waring LW, Edmund JM. A criterion for the reliable use of MRI-only radiotherapy. Radiat Oncol 2014; 9:16. [PMID: 24405515 PMCID: PMC3909342 DOI: 10.1186/1748-717x-9-16] [Citation(s) in RCA: 69] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2013] [Accepted: 12/23/2013] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND MRI-only radiotherapy will eliminate the systematic registration errors introduced when transferring MRI information to the CT. However, challenges concerning the missing information on electron density, necessary for dose calculation and patient setup on bony anatomy are introduced. This study presents a possible statistical approach to evaluate, if deviations based on MRI-only radiotherapy as compared to the CT based radiotherapy are acceptable. METHODS 18 head-and-neck, 21 prostate, 10 vesica and 8 pelvic patients were included in the study. Data from each patient contained a CT and a T2-weighted MRI scan, a structure set and a clinically approved CT based treatment plan, which was re-calculated with identical parameters on the density corrected MRI scans. A statistical analysis including a 95% confidence interval was performed in clinically relevant DVH points. RESULTS The mean differences in the investigated DVH points were in the order of 1.5% for the PTV and up to 4.2% for organs at risk. In addition, a proposed criterion of 2% dose difference in the PTV coverage for 95% of the patients was fulfilled for all diagnostic groups for a bulk segmented MRI in the DVH points, D(median) and D2%, while only head-and-neck and prostate further fulfilled the criterion in D98%. CONCLUSION Here, we suggested a method for establishing a reliable use of MRI-only radiotherapy. A population-based study comparing CT based dose calculations with those obtained on a suggested segmentation of MRI should be initiated and acceptable deviations in clinically relevant DVH points should be established. Such a population-based approach could form a part of the clinical commissioning of MRI-only radiotherapy.
Collapse
Affiliation(s)
- Marie E Korsholm
- Department of Oncology, Radiotherapy Research Unit (52AA), Herlev Hospital, University of Copenhagen, Herlev, Denmark
| | - Line W Waring
- Department of Biomedical Sciences and The Danish National Research Foundation Centre for Cardiac Arrhythmia, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
| | - Jens M Edmund
- Department of Oncology, Radiotherapy Research Unit (52AA), Herlev Hospital, University of Copenhagen, Herlev, Denmark
| |
Collapse
|
18
|
Radioterapia externa: lo que el médico general debe saber. REVISTA MÉDICA CLÍNICA LAS CONDES 2013. [DOI: 10.1016/s0716-8640(13)70210-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
19
|
Subedi KS, Takahashi T, Yamano T, Saitoh JI, Nishimura K, Suzuki Y, Ohno T, Nakano T. Usefulness of double dose contrast-enhanced magnetic resonance imaging for clear delineation of gross tumor volume in stereotactic radiotherapy treatment planning of metastatic brain tumors: a dose comparison study. JOURNAL OF RADIATION RESEARCH 2013; 54:135-139. [PMID: 22843378 PMCID: PMC3534262 DOI: 10.1093/jrr/rrs053] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/03/2012] [Revised: 05/23/2012] [Accepted: 06/13/2012] [Indexed: 06/01/2023]
Abstract
The purpose of this study was to compare the size and clearness of gross tumor volumes (GTVs) of metastatic brain tumors on T1-weighted magnetic resonance images between a single dose contrast administration protocol and a double dose contrast administration protocol to determine the optimum dose of contrast-enhancement for clear delineation of GTV in stereotactic radiotherapy (SRT). A total of 28 small metastatic brain tumors were evaluated in 13 patients by intra-individual comparison of GTV measurements using single dose and double dose contrast-enhanced thin-slice (1-mm) magnetic resonance imaging (MRI). All patients had confirmed histological types of primary tumors and had undergone hypo-fractionated SRT for metastatic brain tumors. The mean tumor diameter with single dose and double dose contrast-enhancement was 12.0 ± 1.1 mm and 13.2 ± 1.1 mm respectively (P < 0.001). The mean incremental ratio (MIR) obtained by comparing mean tumor diameters was 11.2 ± 0.02 %. The mean volume of GTV-1 (single dose contrast-enhancement) and GTV-2 (double dose contrast-enhancement) was 1.38 ± 0.41 ml and 1.59 ± 0.45 ml respectively (P < 0.01). The MIR by comparing mean tumor volumes was 32.3 ± 0.4 %. The MIR of GTV-1 with < 1 ml volume and GTV-1 with > 1 ml volume was 41.8 ± 0.05 % and 12.4 ± 0.03 % respectively (P < 0.001). We conclude that double dose contrast-enhanced thin-slice MRI is a more useful technique than single dose contrast-enhanced thin-slice MRI, especially for clear delineation of GTVs of small metastatic brain tumors in treatment planning of highly precise SRT.
Collapse
Affiliation(s)
- Kalloo Sharma Subedi
- Department of Radiation Oncology, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Shenoy A. Clinical applications of imaging biomarkers. Part 3. The neuro-oncologist's perspective. Br J Radiol 2012; 84 Spec No 2:S209-12. [PMID: 22433830 DOI: 10.1259/bjr/38240981] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
Radiation therapy is an important treatment modality in the management of brain tumours. Imaging biomarkers continue to be a focus of active investigation and there is increasing evidence of the utility of biomarkers in refining the overall management plan. This article briefly reviews the literature and outlines the possible clinical applications of imaging biomarkers in neuro-oncology.
Collapse
Affiliation(s)
- A Shenoy
- Clatterbridge Centre for Oncology NHS Foundation Trust, Clatterbridge Road, Bebington, Wirral, UK.
| |
Collapse
|
21
|
Cho KH, Choi JH, Kim JY, Lee SH, Yoo H, Shin KH, Kim TH, Moon SH, Lee SH, Park HC. Volumetric response evaluation after intensity modulated radiotherapy in patients with supratentorial gliomas. Technol Cancer Res Treat 2012; 11:41-8. [PMID: 22181330 DOI: 10.7785/tcrt.2012.500233] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Radiotherapy is frequently indicated to treat cerebral gliomas. Accurate response evaluation after radiotherapy is essential to determine the efficacy of treatment. We retrospectively analyzed the volumetric tumor response after simultaneous integrated boost-intensity modulated radiotherapy (SIB-IMRT) in patients with gliomas. Thirty-five patients (Grade II, 7 patients; Grade III, 12; and Grade IV, 16) were treated with SIB-IMRT with a median total dose of 55.9 Gy/26 fractions for Grade II and 60 Gy/25 fractions for Grade III-IV tumors. Tumor responses were evaluated for enhancing volume on post-gadolinium T1-weighted images (Vgd) and hyper-intensity volume on T2-weighted FLAIR images (V(fl)) on serial MRIs. With the median follow-up of 24.0 months, overall response rates (RRs) were 57% for V(gd) and 51% for V(fl). Tumor grade was predictive of response favoring the lower grade in Vfl with RRs of 86% for Grade II, 75% for Grade III, and 19% for Grade IV tumors (p = 0.004). Time to 50% or greater volume reduction (T50) in Vgd was 8 months for grade III. The T50 in V(fl) was approximately 24 months both for Grade II and III tumors. Majority of Grade IV tumors continued to progress and never reached the T50 in Vgd or Vfl. Responders survived longer than non-responders for V(gd) and V(fl). Volume response after radiotherapy was dependent upon tumor grade and time. LGGs are very responsive to radiotherapy with the RRs of 86% in V(fl). The response of Vfl is more protracted compared to V(gd). Further investigation is needed to determine the clinical significance of volumetric response evaluation.
Collapse
Affiliation(s)
- K H Cho
- Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Karotki A, Mah K, Meijer G, Meltsner M. Comparison of bulk electron density and voxel-based electron density treatment planning. J Appl Clin Med Phys 2011; 12:3522. [PMID: 22089006 PMCID: PMC5718732 DOI: 10.1120/jacmp.v12i4.3522] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2010] [Revised: 05/10/2011] [Accepted: 05/13/2011] [Indexed: 12/04/2022] Open
Abstract
The use of magnetic resonance imaging (MRI) alone for radiation planning is limited by the lack of electron density for dose calculations. The purpose of this work is to evaluate the dosimetric accuracy of using bulk electron density as a substitute for computed tomography (CT)‐derived electron density in intensity‐modulated radiation therapy (IMRT) treatment planning of head and neck (HN) cancers. Ten clinically‐approved, CT‐based IMRT treatment plans of HN cancer were used for this study. Three dose distributions were calculated and compared for each treatment plan. The first calculation used CT‐derived density and was assumed to be the most accurate. The second calculation used a homogeneous patient density of 1 g/cm3. For the third dose calculation, bone and air cavities were contoured and assigned a uniform density of 1.5 g/cm3 and 0 g/cm3, respectively. The remaining tissues were assigned a density of 1 g/cm3. The use of homogeneous anatomy resulted in up to 4%–5% deviations in dose distribution as compared to CT‐derived electron density calculations. Assigning bulk density to bone and air cavities significantly improved the accuracy of the dose calculations. All parameters used to describe planning target volume coverage were within 2% of calculations based on CT‐derived density. For organs at risk, most of the parameters were within 2%, with the few exceptions located in low‐dose regions. The data presented here show that if bone and air cavities are overridden with the proper density, it is feasible to use a bulk electron density approach for accurate dose calculation in IMRT treatment planning of HN cancers. This may overcome the problem of the lack of electron density information should MRI‐only simulation be performed. PACS number: 87.55.D‐
Collapse
Affiliation(s)
- Aliaksandr Karotki
- Department of Medical Physics, Sunnybrook Health Sciences Center, Toronto, ON, Canada.
| | | | | | | |
Collapse
|
23
|
Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, Macdonald DR, Van den Bent MJ, Chang SM. Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas. Neurosurgery 2011; 70:234-43; discussion 243-4. [DOI: 10.1227/neu.0b013e318223f5a7] [Citation(s) in RCA: 178] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Abstract
BACKGROUND
The Response Assessment in Neuro-Oncology (RANO) Working Group is an international, multidisciplinary effort to develop new standardized response criteria for clinical trials in brain tumors. The RANO group identified knowledge gaps relating to the definitions of tumor response and progression after the use of surgical or surgically based treatments.
OBJECTIVE
To outline a proposal for new response and progression criteria for the assessment of the effects of surgery and surgically delivered therapies for patients with gliomas.
METHODS
The Surgery Working Group of RANO identified surgically related end-point evaluation problems that were not addressed in the original Macdonald criteria, performed an extensive literature review, and used a consensus-building process to develop recommendations for how to address these issues in the setting of clinical trials.
RESULTS
Recommendations were formulated for surgically related issues, including imaging changes associated with surgical resection or surgically mediated adjuvant local therapies, the determination of progression in the setting where all enhancing tumor has been removed, and how new enhancement should be interpreted in the setting where local therapies that are known to produce nonspecific enhancement have been used. Additionally, the terminology used to describe the completeness of surgical resections has been recognized to be inconsistently applied to enhancing vs nonenhancing tumors, and a new set of descriptors is proposed.
CONCLUSION
The RANO process is intended to produce end-point criteria for clinical trials that take into account the effects of prior and ongoing therapies. The RANO criteria will continue to evolve as new therapies and technologies are introduced into clinical trial and/or practice.
Collapse
Affiliation(s)
- Michael A. Vogelbaum
- Brain Tumor and Neuro-Oncology Center, Department of Neurosurgery, Cleveland Clinic, Cleveland Ohio
| | - Sarah Jost
- Ivy Center for Advanced Brain Tumor Treatment, Department of Neurosurgery, Swedish Neuroscience Institute, Seattle, Washington
| | - Manish K. Aghi
- Department of Neurological Surgery, University of California, San Francisco, California
| | - Amy B. Heimberger
- Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, Texas
| | - John H. Sampson
- Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina
| | - Patrick Y. Wen
- Center for Neuro-Oncology, Dana Farber/Brigham and Women's Cancer Center and Division of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
| | - David R. Macdonald
- Department of Oncology, Medical Oncology, London Regional Cancer Program, University of Western Ontario, London, Ontario, Canada
| | - Martin J. Van den Bent
- Neuro-Oncology Unit, Daniel den Hoed Cancer Center/Erasmus University Hospital Rotterdam, Rotterdam, the Netherlands
| | - Susan M. Chang
- Division of Neuro-Oncology, Department of Neurological Surgery, University of California, San Francisco, California
| |
Collapse
|
24
|
Hanna GG, Hounsell AR, O'Sullivan JM. Geometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods. Clin Oncol (R Coll Radiol) 2010; 22:515-25. [PMID: 20554168 DOI: 10.1016/j.clon.2010.05.006] [Citation(s) in RCA: 91] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2009] [Revised: 03/16/2010] [Accepted: 05/04/2010] [Indexed: 01/08/2023]
Abstract
Radiotherapy target volume definition is a critical step in the radiotherapy treatment planning process for all tumour sites. New technology may improve the identification of tumour from normal tissue for the purposes of target volume definition. In assessing the proffered benefits of new technologies, rigorous methods of comparison are necessary. A review of published studies was conducted using PubMed (National Library of Medicine) between 1 January 1995 and 1 January 2009 using predefined search terms. The frequency of usage of the various methods of geometrical comparison (simple volume assessment, centre of mass analysis, concordance index and volume edge analysis) was recorded. Sixty-three studies were identified, across a range of primary tumour sites. The most common method of target volume analysis was simple volume measurement; this was described in 84% of the papers analysed. The concordance index type analysis was described in 30%, the centre of mass analysis in 9.5% and the volume edge analysis in 4.8%. In reporting geometrical differences between target volumes no standard exists. However, to optimally describe geometrical changes in target volumes, simple volume change and a measure of positional change should be assessed.
Collapse
Affiliation(s)
- G G Hanna
- Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, UK.
| | | | | |
Collapse
|
25
|
Buhl SK, Duun-Christensen AK, Kristensen BH, Behrens CF. Clinical evaluation of 3D/3D MRI-CBCT automatching on brain tumors for online patient setup verification - A step towards MRI-based treatment planning. Acta Oncol 2010; 49:1085-91. [PMID: 20831500 DOI: 10.3109/0284186x.2010.498442] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
BACKGROUND Magnetic Resonance Imaging (MRI) is often used in modern day radiotherapy (RT) due to superior soft tissue contrast. However, treatment planning based solely on MRI is restricted due to e.g. the limitations of conducting online patient setup verification using MRI as reference. In this study 3D/3D MRI-Cone Beam CT (CBCT) automatching for online patient setup verification was investigated. MATERIAL AND METHODS Initially, a multi-modality phantom was constructed and used for a quantitative comparison of CT-CBCT and MRI-CBCT automatching. Following the phantom experiment three patients undergoing postoperative radiotherapy for malignant brain tumors received a weekly CBCT. In total 18 scans was matched with both CT and MRI as reference. The CBCT scans were acquired using a Clinac iX 2300 linear accelerator (Varian Medical Systems) with an On-Board Imager (OBI). RESULTS For the phantom experiment CT-CBCT and MRI-CBCT automatching resulted in similar results. A significant difference was observed only in the longitudinal direction where MRI-CBCT resulted in the best match (mean and standard deviations of 1.85±2.68 mm for CT and -0.05±2.55 mm for MRI). For the clinical experiment the absolute difference in couch shift coordinates acquired from MRI-CBCT and CT-CBCT automatching, were ≤2 mm in the vertical direction and ≤3 mm in the longitudinal and lateral directions. For yaw rotation differences up to 3.3 degrees were observed. Mean values and standard deviations were 0.8±0.6 mm, 1.5±1.2 mm and 1.2±1.2 mm for the vertical, longitudinal and lateral directions, respectively and 1.95±1.12 degrees for the rotation (n=17). CONCLUSION It is feasible to use MRI as reference when conducting 3D/3D CBCT automatching for online patient setup verification. For both the phantom and clinical experiment MRI-CBCT performed similar to CT-CBCT automatching and significantly better in the longitudinal direction for the phantom experiment.
Collapse
Affiliation(s)
- Sune K Buhl
- Department of Oncology, Copenhagen University Hospital, DK-2730 Herlev, Denmark.
| | | | | | | |
Collapse
|
26
|
Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. Utilization of advanced imaging technologies for target delineation in radiation oncology. J Am Coll Radiol 2009; 6:876-83. [PMID: 19945044 DOI: 10.1016/j.jacr.2009.08.006] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2009] [Accepted: 08/03/2009] [Indexed: 11/26/2022]
Abstract
PURPOSE The aim of this study was to evaluate the utilization of advanced imaging technologies for target delineation among radiation oncologists in the United States. METHODS A random sample of 1,600 radiation oncologists was contacted by Internet, e-mail, and fax and questioned regarding the use of advanced imaging technologies, clinical applications, and future plans for use. Advanced imaging technologies were defined as any of the following that were directly incorporated into radiation therapy planning: MRI, PET, single-photon emission CT, 4-D CT, functional MRI, and MR spectroscopy. RESULTS Of 1,089 contactable physicians, 394 (36%) responded. Of respondents, 65% were in private practice and 35% were in academic practice. The proportion using any advanced imaging technology for target delineation was 95%. However, the majority reported only rare (in <25% of their patients; 46.6%) or infrequent (in 25%-50% of their patients; 26.0%) utilization. The most commonly used technologies were 2-[(18)F]fluoro-2-deoxyglucose PET (76%), MRI (72%), and 4-D CT (44%). The most common cancers treated using image-guided target delineation were those of the lung (83%), central nervous system (79%), and head and neck (79%). Among users of advanced imaging technologies, 66% planned to increase use; 30% of nonusers planned to adopt these technologies in the future. CONCLUSIONS Advanced imaging technologies are widely used by US radiation oncologists for target delineation. Although the majority of respondents used them in <50% of their patients, the frequency of utilization is expected to increase. Studies determining the optimal application of these technologies in radiation therapy planning are needed.
Collapse
Affiliation(s)
- Daniel R Simpson
- Department of Radiation Oncology and Center for Advanced Radiotherapy Technologies, Rebecca and John Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, California 92093-0843, USA
| | | | | | | | | | | |
Collapse
|
27
|
Dedicated Magnetic Resonance Imaging in the Radiotherapy Clinic. Int J Radiat Oncol Biol Phys 2009; 74:644-51. [DOI: 10.1016/j.ijrobp.2009.01.065] [Citation(s) in RCA: 118] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2008] [Revised: 01/09/2009] [Accepted: 01/14/2009] [Indexed: 11/21/2022]
|
28
|
Wang X, Li L, Hu C, Qiu J, Xu Z, Feng Y. A comparative study of three CT and MRI registration algorithms in nasopharyngeal carcinoma. J Appl Clin Med Phys 2009; 10:3-10. [PMID: 19458592 PMCID: PMC5720458 DOI: 10.1120/jacmp.v10i2.2906] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2008] [Revised: 01/15/2009] [Accepted: 02/01/2009] [Indexed: 12/03/2022] Open
Abstract
Objective: To evaluate the image registration accuracy and efficiency of CT and MRI fusion using three algorithms in nasopharyngeal carcinoma (NPC). Methods and materials: Twelve sets of CT and MRI scans of 12 NPC patients were fused using three image registration algorithms, respectively: Mark‐and‐link, Interactive, and Normalized Mutual Information (NMI). Registration accuracy was evaluated by performing statistical analysis of the coordinate differences between CT and MR anatomical landmarks along the x‐, y‐ and z‐axes. The time required to complete the registration process using three algorithms was also recorded. One‐way ANOVA was used to analyze the difference of the three registration methods. Results: The mean time required for CT/MRI registration using the three different registration algorithms, mark‐and‐link, interactive, and NMI, was 6.25 min, 5.25 min, and 5.15 min, respectively. The mark‐and‐link method was more time consuming (F=8.74,p=0.001); however no statistical difference was found between the time required using interactive and NMI methods (p=0.77). Mean registration errors of the three methods along the x‐axis were 0.66 mm, 0.70 mm, and 0.68 mm, respectively (F=0.09,p=0.91). Along the y‐axis, the mean registration errors were 1.03 mm, 1.04 mm, and 1.03 mm, respectively (F=0.02,p=0.98). Along the z‐axis, they were 0.58 mm, 0.64 mm, and 0.56 mm, respectively (F=0.21,p=0.81). Conclusions: All three registration algorithms, mark‐and‐link, interactive, and NMI, can provide accurate CT/MRI registration. However the mark‐and‐link method was most time consuming. PACS number: 87.57.nj
Collapse
Affiliation(s)
- XiaoShen Wang
- Department of Radiation Oncology, Cancer Hospital, Fudan University, Shanghai, People's Republic of China, 200032
| | - LongGen Li
- Department of Radiation Oncology, Cancer Hospital, Fudan University, Shanghai, People's Republic of China, 200032
| | - ChaoSu Hu
- Department of Radiation Oncology, Cancer Hospital, Fudan University, Shanghai, People's Republic of China, 200032
| | - JianJian Qiu
- Department of Radiation Oncology, Cancer Hospital, Fudan University, Shanghai, People's Republic of China, 200032
| | - ZhiYong Xu
- Department of Radiation Oncology, Cancer Hospital, Fudan University, Shanghai, People's Republic of China, 200032
| | - Yan Feng
- Department of Radiation Oncology, Cancer Hospital, Fudan University, Shanghai, People's Republic of China, 200032
| |
Collapse
|
29
|
Viard R. Présentation des différentes avancées techniques en imagerie interventionnelle par résonance magnétique. Ing Rech Biomed 2009. [DOI: 10.1016/j.irbm.2008.12.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
30
|
Jefferies S, Taylor A, Reznek R. Results of a national survey of radiotherapy planning and delivery in the UK in 2007. Clin Oncol (R Coll Radiol) 2009; 21:204-17. [PMID: 19250811 DOI: 10.1016/j.clon.2008.11.017] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2008] [Revised: 11/17/2008] [Accepted: 11/18/2008] [Indexed: 01/12/2023]
Abstract
AIMS Technical developments in radiotherapy have increased very rapidly over recent years, resulting in the processes of radiotherapy planning and delivery changing significantly. It is essential that alongside these developments, optimal methods for accurate target volume definition become a priority. The Radiotherapy Imaging for Delivery of Radiotherapy Working Party was formed to create a framework for imaging for radiotherapy planning and delivery: the areas of interest were interpretation of imaging for planning, optimum acquisition of imaging for radiotherapy planning and training and assessment across all staff groups involved with radiotherapy planning. A detailed assessment of the current situation in the UK was needed to prepare for this document. A national survey was undertaken and the results are reported in this paper. MATERIALS AND METHODS A questionnaire was sent to all NHS radiotherapy departments in the UK on 3 occasions in 2007. A total of 48 replies were received from 58 centres giving a response rate of 83%. RESULTS Approximately half of centres (46%) in the UK use IMRT. Thirteen centres are using IMRT in the routine management of patients. Nine centres indicated that they use IMRT routinely within the research setting. Twenty-six centres are not using IMRT but 10 centres are planning to implement the technology within 12 months. Only 4 centres in the UK routinely use IGRT and 6 centres report use of image guidance in the research setting. Twelve centres are planning to implement this over 12 months. Few oncologists have dedicated radiology input for planning. Twenty-seven centres had help from radiologists on an ad hoc basis only and 10 centres had no input at all. Only 2 centres have formal radiology training for trainees and 9 centres report ad hoc time with diagnostic radiologists or cite the FRCR course as the main sources of training. Twelve centres have structured training for radiographers and 4 centres for medical physicists. CONCLUSIONS This survey assessed radiotherapy planning and delivery within the UK in 2007. The most significant findings were the lack of implementation of IMRT and IGRT which appeared to mainly to be due to lack of available staff, such as medical physicists, insufficient access to existing equipment, lack of time for more complex radiotherapy planning and insufficient funding. A further concern is the lack of formal training in tumour and normal tissue outlining across several staff groups.
Collapse
Affiliation(s)
- S Jefferies
- Department of Clinical Oncology, Oncology Centre, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK.
| | | | | |
Collapse
|
31
|
|
32
|
Abstract
The goal of radiation therapy is to achieve maximal therapeutic benefit expressed in terms of a high probability of local control of disease with minimal side effects. Physically this often equates to the delivery of a high dose of radiation to the tumour or target region whilst maintaining an acceptably low dose to other tissues, particularly those adjacent to the target. Techniques such as intensity modulated radiotherapy (IMRT), stereotactic radiosurgery and computer planned brachytherapy provide the means to calculate the radiation dose delivery to achieve the desired dose distribution. Imaging is an essential tool in all state of the art planning and delivery techniques: (i) to enable planning of the desired treatment, (ii) to verify the treatment is delivered as planned and (iii) to follow-up treatment outcome to monitor that the treatment has had the desired effect. Clinical imaging techniques can be loosely classified into anatomic methods which measure the basic physical characteristics of tissue such as their density and biological imaging techniques which measure functional characteristics such as metabolism. In this review we consider anatomical imaging techniques. Biological imaging is considered in another article. Anatomical imaging is generally used for goals (i) and (ii) above. Computed tomography (CT) has been the mainstay of anatomical treatment planning for many years, enabling some delineation of soft tissue as well as radiation attenuation estimation for dose prediction. Magnetic resonance imaging is fast becoming widespread alongside CT, enabling superior soft-tissue visualization. Traditionally scanning for treatment planning has relied on the use of a single snapshot scan. Recent years have seen the development of techniques such as 4D CT and adaptive radiotherapy (ART). In 4D CT raw data are encoded with phase information and reconstructed to yield a set of scans detailing motion through the breathing, or cardiac, cycle. In ART a set of scans is taken on different days. Both allow planning to account for variability intrinsic to the patient. Treatment verification has been carried out using a variety of technologies including: MV portal imaging, kV portal/fluoroscopy, MVCT, conebeam kVCT, ultrasound and optical surface imaging. The various methods have their pros and cons. The four x-ray methods involve an extra radiation dose to normal tissue. The portal methods may not generally be used to visualize soft tissue, consequently they are often used in conjunction with implanted fiducial markers. The two CT-based methods allow measurement of inter-fraction variation only. Ultrasound allows soft-tissue measurement with zero dose but requires skilled interpretation, and there is evidence of systematic differences between ultrasound and other data sources, perhaps due to the effects of the probe pressure. Optical imaging also involves zero dose but requires good correlation between the target and the external measurement and thus is often used in conjunction with an x-ray method. The use of anatomical imaging in radiotherapy allows treatment uncertainties to be determined. These include errors between the mean position at treatment and that at planning (the systematic error) and the day-to-day variation in treatment set-up (the random error). Positional variations may also be categorized in terms of inter- and intra-fraction errors. Various empirical treatment margin formulae and intervention approaches exist to determine the optimum strategies for treatment in the presence of these known errors. Other methods exist to try to minimize error margins drastically including the currently available breath-hold techniques and the tracking methods which are largely in development. This paper will review anatomical imaging techniques in radiotherapy and how they are used to boost the therapeutic benefit of the treatment.
Collapse
Affiliation(s)
- Philip M Evans
- Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK.
| |
Collapse
|
33
|
Kristensen BH, Laursen FJ, Løgager V, Geertsen PF, Krarup-Hansen A. Dosimetric and geometric evaluation of an open low-field magnetic resonance simulator for radiotherapy treatment planning of brain tumours. Radiother Oncol 2008; 87:100-9. [PMID: 18262669 DOI: 10.1016/j.radonc.2008.01.014] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2007] [Revised: 12/19/2007] [Accepted: 01/13/2008] [Indexed: 11/25/2022]
Abstract
BACKGROUND AND PURPOSE Magnetic resonance (MR) imaging is superior to computed tomography (CT) in radiotherapy of brain tumours. In this study an open low-field MR-simulator is evaluated in order to eliminate the cost of and time spent on additional CT scanning. MATERIALS AND METHODS Eleven patients with brain tumours are both CT and MR scanned and the defined tumour volumes are compared. Image distortions and dose calculations based on CT density correction, MR unit density and MR bulk density, bone segmentation are performed. Monte Carlo simulations using 4 and 8 MV beams on homogeneous and bone segmented mediums are performed. RESULTS Mean MR and CT tumour volumes of approximately the same size (V MR =55+/-34 cm3 and V CT =51+/-32 cm3) are observed, but for individual patients, small intersection volumes are observed. The MR images show negligible distortion within radial distances below 12 cm (<1.5 mm). On unit density mediums, dose errors above 2% are observed in low dose areas. Monte Carlo simulations with 4 MV photons show large deviations in dose (>2%) just behind the skull if bone is not segmented. CONCLUSIONS It is feasible to use an MR-simulator for radiotherapy planning of brain tumours if bone is segmented or a careful choice of beam energy (>4 MV) is selected.
Collapse
|
34
|
Viard R, Rousseau J. [Interventional MR imaging: state of the art and technological advances]. JOURNAL DE RADIOLOGIE 2008; 89:13-20. [PMID: 18288022 DOI: 10.1016/s0221-0363(08)70365-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
Due to its excellent soft tissue contrast and lack of ionizing radiation, MR imaging is well suited for interventional procedures. MRI is being increasingly used for guidance during percutaneous procedures or surgery. Technical advances in interventional MR imaging are reviewed in this paper. Ergonomical factors with improved access to patients as well as advances in informatics, electronics and robotics largely explain this increasing role. Different elements are discussed from improved access to patients in the scanners to improved acquisition pulse sequences. Selected clinical applications and recent publications will be presented to illustrate the current status of this technique.
Collapse
Affiliation(s)
- R Viard
- INSERM, U703, ITM, Pavillon Vancostenobel, CHRU de Lille, 2 avenue Oscar Lambret, 59000 Lille Cedex.
| | | |
Collapse
|
35
|
Abstract
The goal of radiation therapy is to eradicate tumor stem cells while sparing healthy tissue. Therefore, the first aim must be to delineate tumor from healthy tissue. Advanced imaging techniques will enable one to reduce the uncertainty of microscopic extension of disease. Ultimately, advanced functional imaging systems correlated with image-registered pathological specimens will allow one to delineate disease extent from normal tissue at the tumor periphery. When it is not possible to determine the CTV margin with reasonable certainty, the margins must remain generous and conformal avoidance methodology could and should be deployed to spare critical normal structures. Of equal importance to defining the CTV is the need to guarantee that this target is indeed treated. For this purpose, image guidance using a variety of systems including portal images, ultrasound devices, and CT scanners at the time of treatment has been implemented. Some image-guided methods, portal images for instance, are more amenable for use with rigid structures such as encountered in the sinus whereas others like ultrasound or CT scanners are able to account for nonrigid setup variations. Several strategies for preventing organ motion from degrading the precision that radiotherapy offers have been described. In particular, a CT scan at the time of treatment delivery can also be used as the basis to reconstruct the dose received by the patient. Dose reconstruction will allow the dose just delivered to be superimposed on the pretreatment CT scan and will allow one to compare the reconstructed delivered dose distribution with the planned dose distribution to assess discrepancies between these. Furthermore, reconstruction of the delivered dose distributions holds the promise of allowing one to accumulate dose delivered to the tumor and normal structures on a fraction per fraction basis. This will ultimately allow for the determination of treatment-specific tumor control probabilities and normal tissue complication probabilities.
Collapse
Affiliation(s)
- Thomas Rockwell Mackie
- Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, USA
| | | |
Collapse
|
36
|
Weber DC, Wang H, Albrecht S, Ozsahin M, Tkachuk E, Rouzaud M, Nouet P, Dipasquale G. Open low-field magnetic resonance imaging for target definition, dose calculations and set-up verification during three-dimensional CRT for glioblastoma multiforme. Clin Oncol (R Coll Radiol) 2007; 20:157-67. [PMID: 17936601 DOI: 10.1016/j.clon.2007.09.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2007] [Revised: 07/02/2007] [Accepted: 09/03/2007] [Indexed: 11/28/2022]
Abstract
AIMS To assess the effect on target delineation of using magnetic resonance simulation for planning of glioblastoma multiforme (GBM). Dose calculations derived from computed tomography- and magnetic resonance-derived plans were computed. The accuracy of set-up verification using magnetic resonance imaging (MRI)-based digital reconstructed radiographs (DRRs) was assessed. MATERIALS AND METHODS Ten patients with GBM were simulated using computed tomography and MRI. MRI was acquired with a low-field (0.23 T) MRI unit (SimMRI). Gross tumour volumes (GTVs) were delineated by two radiation oncologists on computed tomography and MRI. In total, 30 plans were generated using both the computed tomography, with (planbathoCT) and without (planCT) heterogeneity correction, and MRI data sets (planSimMRI). The minimum dose delivered (Dmin) to the GTV between computed tomography- and MRI-based plans was compared. The accuracy of set-up positioning using MRI DRRs was assessed by four radiation oncologists. RESULTS The mean GTVs delineated on computed tomography were significantly (P<0.001) larger than those contoured on MRI. The mean (+/-standard deviation) Dmin difference percentage was 0.3+/-0.8, 0.1+/-0.6 and -0.2+/-1.0% for the planCT/planbathoCT-, planCT/planSimMRI- and planbathoCT/planSimMRI-derived plans, respectively. The set-up differences observed with the computed tomography and MRI DRRs ranged from 1.0 to 4.0 mm (mean 1.5 mm; standard deviation+/-1.4). CONCLUSIONS GTVs defined on computed tomography were significantly larger than those delineated on MRI. Compared with computed tomography-derived plans, MRI-based dose calculations were accurate. The precision of set-up verifications based on computed tomography- and MRI-derived DRRs seemed similar. The use of MRI only for the planning of GBM should be further assessed.
Collapse
Affiliation(s)
- D C Weber
- Department of Radiation Medicine, Paul Scherrer Institute, Villigen-PSI, Switzerland.
| | | | | | | | | | | | | | | |
Collapse
|
37
|
Yeh SA, Huang YJ. Dose Escalation for Patients With Locally Advanced Nasopharyngeal Carcinoma Treated With Radiotherapy Alone. Am J Clin Oncol 2007; 30:401-5. [PMID: 17762441 DOI: 10.1097/coc.0b013e31803377b3] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVES The local control of patients with locally advanced nasopharyngeal carcinoma is still unsatisfactory. This prospective study was designed to evaluate the treatment outcomes and treatment-related complications of patients with locally advanced nasopharyngeal carcinoma treated with escalated radiation doses. METHODS A total of 118 consecutive patients with T4 classification (1992 American Joint Committee on Cancer staging system), histology-proven nonmetastatic nasopharyngeal carcinoma were treated with radiotherapy alone between 1992 and 1997 in a medical center in southern Taiwan. Thirty-two of them were enrolled into a prospective study of dose escalation and were irradiated to a total of 81 Gy. The other 86 patients received a total of 70.2 Gy. Potentially significant patient-related and treatment-related parameters were analyzed for their prognostic significance. Radiation-related complications were recorded and analyzed. RESULTS The 5-year local progression-free rates were 61%, and 61% for patients receiving 70.2 Gy and 81 Gy, respectively (P > 0.05). The incidences of xerostomia, hearing impairment, and temporal radionecrosis were significantly higher for those receiving 81 Gy. The 5-year complication-free rates of patients receiving 70.2 Gy and 81 Gy were 14% versus 2% for xerostomia (P = 0.0070), 50% versus 30% for hearing impairment (P = 0.0198), and 91% versus 82% for temporal radionecrosis (P = 0.0400). CONCLUSIONS For patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone, dose escalation to 81 Gy failed to show benefits on local control rate. Higher radiation doses contribute to a higher incidence of radiation-related complications.
Collapse
Affiliation(s)
- Shyh-An Yeh
- Department of Radiation Oncology, E-DA Hospital, Kaohsiung, Taiwan.
| | | |
Collapse
|
38
|
Zhang P, Osterman KS, Liu T, Li X, Kessel J, Wu L, Schiff P, Kutcher GJ. How does performance of ultrasound tissue typing affect design of prostate IMRT dose-painting protocols? Int J Radiat Oncol Biol Phys 2007; 67:362-8. [PMID: 17236962 PMCID: PMC2901543 DOI: 10.1016/j.ijrobp.2006.08.061] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2006] [Revised: 08/03/2006] [Accepted: 08/24/2006] [Indexed: 10/23/2022]
Abstract
PURPOSE To investigate how the performance characteristics of ultrasound tissue typing (UTT) affect the design of a population-based prostate dose-painting protocol. METHODS AND MATERIALS The performance of UTT is evaluated using the receiver operating characteristic curve. As the imager's sensitivity increases, more tumors are detected, but the specificity worsens, causing more false-positive results. The UTT tumor map, obtained with a specific sensitivity and specificity setup, was used with the patient's CT image to guide intensity-modulated radiotherapy (IMRT) planning. The optimal escalation dose to the UTT positive region, as well as the safe dose to the negative background, was obtained by maximizing the uncomplicated control (i.e., a combination of tumor control probability and weighted normal tissue complication probability). For high- and low-risk tumors, IMRT plans guided by conventional ultrasound or UTT with a one-dimensional or two-dimensional spectrum analysis technique were compared with an IMRT plan in which the whole prostate was dose escalated. RESULTS For all imaging modalities, the specificity of 0.9 was chosen to reduce complications resulting from high false-positive results. If the primary tumors were low risk, the IMRT plans guided by all imaging modalities achieved high tumor control probability and reduced the normal tissue complication probability significantly compared with the plan with whole gland dose escalation. However, if the primary tumors were high risk, the accuracy of the imaging modality was critical to maintain the tumor control probability and normal tissue complication probability at acceptable levels. CONCLUSION The performance characteristics of an imager have important implications in dose painting and should be considered in the design of dose-painting protocols.
Collapse
Affiliation(s)
- Pengpeng Zhang
- Department of Radiation Oncology, Columbia University Medical Center, New York, NY 10032-3784, USA.
| | | | | | | | | | | | | | | |
Collapse
|
39
|
McJury M, Dyker K, Nakielny R, Conway J, Robinson MH. Optimizing localization accuracy in head and neck, and brain radiotherapy. Br J Radiol 2006; 79:672-80. [PMID: 16641422 DOI: 10.1259/bjr/14663755] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
The purpose of this study was to investigate the impact on localization of utilizing contrast-enhanced CT scans and the formal input of a radiologist in the planning process. 25 head and neck/brain patients had pre- and post-contrast CT scans in the treatment position. Radiotherapy treatment was planned on the unenhanced CT images as per standard practice. Retrospectively, their scans (unenhanced and enhanced) were re-contoured by two oncologists and a radiologist. These new contours were compared with the original unenhanced treatment contours and differences in contour volume, geographical isocentre position and tolerance coverage of the associated planning target volumes (PTVs) were evaluated using the original plans. The use of contrast enhanced CT data during localization by the oncologist shows little change in gross tumour volumes (GTVs) or PTVs, geographical position or tolerance coverage for the targets in the brain studied here. Larger changes in mean volume are seen for the head and neck cases alone. Changes are greater and statistically significant (p < 0.05, Wilcoxon signed rank test) for localization by the radiologist. Furthermore, when comparing the original PTV marked by the oncologist with a new PTV re-contoured by the oncologist, but based on a GTV marked-up by the radiologist, again statistically significant (p < 0.01) changes in percentage volume are noted. Intraoperator precision is good, percentage volume differences being of the order 3-6%. PTVs also show improved standard deviations compared with GTVs. Geographic shifts are generally within our departmental tolerance levels for daily patient setup. Comparing precision of unenhanced data with enhanced, mean percentage volume changes are smaller, but not statistically significant. The use of enhanced scan data for localization has little effect on size, geographical position or tolerance coverage of PTVs marked up by the oncologists in this study. However, more important is the input from a radiologist. Statistically significant differences due to mark-up on enhanced scans by the radiologist are shown. Furthermore, significant differences are also seen between PTVs based on oncologist-generated GTVs, and those based on radiologist-generated GTVs.
Collapse
Affiliation(s)
- M McJury
- Department of Radiotherapy Physics, Weston Park Hospital, Whitham Road, Sheffield, UK
| | | | | | | | | |
Collapse
|
40
|
Newbold K, Partridge M, Cook G, Sohaib SA, Charles-Edwards E, Rhys-Evans P, Harrington K, Nutting C. Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review. Br J Radiol 2006; 79:554-61. [PMID: 16823059 DOI: 10.1259/bjr/48822193] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Head and neck squamous cell carcinoma represents an ideal model to investigate the application of recent advances in medical imaging to radiotherapy planning. Tumours usually remain localized, and are potentially curable with local radiation. The steep radiation dose-response relationships support the strategies of radiation dose escalation to increase local control. Two-dimensional simulator-based planning and CT planning have significant drawbacks in terms of accurate target volume definition. MRI has enhanced soft tissue delineation, but has to be fused with CT to allow dose calculation. Functional imaging using dynamic contrast enhanced CT or MRI sequences may allow improved knowledge of tumour function. Positron emission tomography (PET) may allow further physiological information to be determined. This review summarizes the current techniques in clinical development in this area.
Collapse
Affiliation(s)
- K Newbold
- The Royal Marsden NHS Trust, Fulham Road, London SW3 6JJ, UK
| | | | | | | | | | | | | | | |
Collapse
|
41
|
Shah GD, Kesari S, Xu R, Batchelor TT, O’Neill AM, Hochberg FH, Levy B, Bradshaw J, Wen PY. Comparison of linear and volumetric criteria in assessing tumor response in adult high-grade gliomas. Neuro Oncol 2006; 8:38-46. [PMID: 16443946 PMCID: PMC1871928 DOI: 10.1215/s1522851705000529] [Citation(s) in RCA: 150] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
The Response Evaluation Criteria in Solid Tumors, or RECIST criteria (one-dimensional [1D] measurement), are widely used to measure response in tumors, but there are few studies evaluating these criteria in brain tumors. We compared linear and volumetric measurements in adult high-grade supratentorial enhancing gliomas to determine the agreement between measurements, in defining responses and in their subsequent relation to survival. We hypothesized that the 1D RECIST criteria maybe suitable for response assessment in adult high-grade gliomas. Tumor size on MRI scans in 104 patients with high-grade enhancing gliomas treated on clinical trial protocols was measured by using 1D (greatest length), 2D (two-dimensional: product of the two longest perpendicular diameters), 3D (three dimensional: product of the longest perpendicular diameters in one plane and the longest orthogonal diameter to that plane), enhancing volume (EV), and total volume (TV). A total of 388 T1 postgadolinium MRI scans (104 baseline and 284 follow-up scans) were evaluated. Volumetric analysis (EV and TV) was performed with commercially available software. Intraobserver and interobserver correlations (rho) were high for all modalities (rho > 0.92 and rho > 0.71, respectively). Correlation was excellent (rho > 0.9) among all modalities except for 3D (rho < 0.6). Patient response rates ranged from 12% to 26%. Median progression-free survival (mPFS) and six-month progression-free survival (6mPFS) were not significantly different among the methods (range, 5.3 months to 5.9 months and 42% to 48%, respectively). Landmark analyses of response at two months using linear methods predicted overall survival with hazard ratios of 0.19 to 0.29 (P < 0.005). These results suggest high concordance among 1D, 2D, TV, and EV, but not 3D, methods in assessing enhancing tumor progression and in estimating mPFS and 6mPFS in adult brain tumor patients. The tumor response at two months assessed by linear methods correlated better with overall survival. Thus, linear methods are comparable to volumetric methods, but simpler to implement for routine clinical use and for designing clinical trials of brain tumors.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Patrick Y. Wen
- Address correspondence to Patrick Y. Wen, Center for Neuro-Oncology, Dana-Farber Cancer Institute and Division of Neuro-Oncology, Department of Neurology, Brigham and Women’s Hospital, SW430D, 44 Binney Street, Boston, MA 02115, USA (
)
| |
Collapse
|
42
|
Cattaneo GM, Reni M, Rizzo G, Castellone P, Ceresoli GL, Cozzarini C, Ferreri AJM, Passoni P, Calandrino R. Target delineation in post-operative radiotherapy of brain gliomas: interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans. Radiother Oncol 2005; 75:217-23. [PMID: 15885831 DOI: 10.1016/j.radonc.2005.03.012] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2004] [Revised: 02/22/2005] [Accepted: 03/08/2005] [Indexed: 11/24/2022]
Abstract
BACKGROUND AND PURPOSE To investigate the interobserver variability of intracranial tumour delineation on computed tomography (CT) scans using pre-operative MR hardcopies (CT+MR(conv)) or CT-MR (pre-operative) registered images (CT+MR(matched)). PATIENTS AND METHODS Five physicians outlined the 'initial' clinical tumour volume (CTV0) of seven patients affected by HGG and candidates for radiotherapy (RT) after radical resection. The observers performed on screen-tumour delineation using post-operative CT images of the patients in the treatment position and pre-operative MR radiographs (CT+MR(conv)); they also outlined CTV0 with both CT and corresponding MR axial image on screen (CT+MR(matched)). The accuracy of the image fusion was quantitatively assessed. An analysis was conducted to assess the variability among the five observers in CT+MR(conv) and CT+MR(matched) modality. RESULTS The registration accuracy in 3D space is always less than 3.7 mm. The concordance index was significantly better in CT+MR(matched) (47.4+/-12.4%) than in CT+MR(conv) (14.1+/-12.7%) modality (P<0.02). The intersecting volumes represent 67+/-15 and 24+/-18% of the patient mean volume for CT+MR(matched) and CT+MR(conv), respectively (P<0.02). CONCLUSIONS The use of CT and MR registered imaging reduces interobserver variability in target volume delineation for post-operative irradiation of HGG; smaller margins around target volume could be adopted in defining irradiation technique.
Collapse
|
43
|
Giraud P, Kantor G, Loiseau H, Rosenzweig KE. Target Definition in the Thorax and Central Nervous System. Semin Radiat Oncol 2005; 15:146-56. [PMID: 15983940 DOI: 10.1016/j.semradonc.2005.01.001] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
It is the aim of conformal radiotherapy to restrict the high-dose region to the target volume as much as possible, thereby sparing the neighboring healthy tissues. However, to increase the therapeutic range, smaller margins tend to be used. This reduction of safety margins enhances the risk of unsuitable dosage because of mistaken target definition. Central nervous system (CNS) and lung cancers constitute sites that are particularly difficult to irradiate combining a large number of conceptual difficulties, allowing them to be considered as 2 particularly interesting study models. Imaging occupies an increasingly important place in these 2 types of tumors, especially with the development of new radiotherapy techniques. CNS and lung cancers represent an example of clinicopathological correlations. More specifically, CNS cancers represent an excellent model for estimation of new 3-dimensional navigational systems. For lung cancer, there is a combination of ballistic difficulties because of respiratory motion, the number and low tolerance of neighboring organs, and dosimetric difficulties because of the presence of inhomogeneities. This article reviews the main currently accepted criteria of choice justifying the size of gross tumor volume and clinical target volume margins for lung and CNS cancers.
Collapse
Affiliation(s)
- Philippe Giraud
- Department of Radiation Oncology, Institut Curie, Paris, France.
| | | | | | | |
Collapse
|
44
|
Aoyama H, Shirato H, Katoh N, Kudo K, Asano T, Kuroda S, Ishikawa T, Miyasaka K. Comparison of imaging modalities for the accurate delineation of arteriovenous malformation, with reference to stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2005; 62:1232-8. [PMID: 15913912 DOI: 10.1016/j.ijrobp.2005.03.039] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2004] [Revised: 03/07/2005] [Accepted: 03/09/2005] [Indexed: 11/29/2022]
Abstract
PURPOSE To investigate the discrepancy between the arteriovenous malformations seen on magnetic resonance angiography (MRA) and on stereotactic digital subtracted angiography (DSA). METHODS AND MATERIALS The target volume on stereotactic DSA (V(DSA)) and the target volume on MRA (V(MRA)) were separately delineated in 28 intracranial arteriovenous malformations. The coordinates of the center and the outer edges of V(DSA) and V(MRA) were calculated and used for the analyses. RESULTS The standard deviations (mean value) of the displacement of centers of V(MRA) from V(DSA) were 2.67 mm (-1.82 mm) in the left-right direction, 3.23 mm (-0.08 mm) in the anterior-posterior direction, and 2.16 mm (0.91 mm) in the craniocaudal direction. V(MRA) covered less than 80% of V(DSA) in any dimensions in 9 cases (32%), although no significant difference was seen in the target volume between each method, with a mean value of 11.9 cc for V(DSA) and 12.3 cc for V(MRA) (p = 0.948). CONCLUSION The shift of centers between each modality is not negligible. Considering no significant difference between V(DSA) and V(MRA), but inadequate coverage of the V(DSA) by V(MRA), it is reasonable to consider that the target on MRA might include the feeding artery and draining vein and possibly miss a portion of the nidus.
Collapse
Affiliation(s)
- Hidefumi Aoyama
- Department of Radiology, Hokkaido University Graduate School of Medicine, North-15 West-7, Sapporo, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
45
|
Böttcher P, Maierl J, Hecht S, Matis U, Liebich HG. Automatic image registration of three-dimensional images of the head of cats and dogs by use of maximization of mutual information. Am J Vet Res 2004; 65:1680-7. [PMID: 15631033 DOI: 10.2460/ajvr.2004.65.1680] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVE To validate mutual information criterion as a ready-to-use technique for automated alignment (ie, registration) of 3-dimensional (3-D) multimodal image data of the head of cats and dogs. SAMPLE POPULATION Corresponding 3-D magnetic resonance imaging (MRI) and computed tomography (CT) brain scans of a 6-month-old Doberman Pinscher with a brain cyst; CT images of the head of a European shorthair cat with a meningioma before and immediately, 3, and 6 months after surgical resection; and CT and corresponding stacked anatomic cryosection images of the entire head of a 2-year-old sexually intact female Beagle. PROCEDURE All images were matched retrospectively by use of an in-house computer program developed on the basis of a mutual information image registration algorithm. Accuracy of the resulting registrations was evaluated by visual inspection. RESULTS All registrations were judged to be highly accurate. Additional manual corrections were not necessary. CONCLUSIONS AND CLINICAL RELEVANCE Mutual information registration criterion can by applied to 3-D multimodal head images of cats and dogs for full automatic rigid-body image registration. The combination of such aligned images would considerably facilitate efforts of veterinary clinicians as indicated by its widespread use in brain surgery and radiation therapy of humans.
Collapse
Affiliation(s)
- Peter Böttcher
- Department of Small Animal Surgery, Faculty of Veterinary Medicine, Ludwig-Maximilians-University, Munich, Germany
| | | | | | | | | |
Collapse
|
46
|
Chang TC, Shirato H, Aoyama H, Ushikoshi S, Kato N, Kuroda S, Ishikawa T, Houkin K, Iwasaki Y, Miyasaka K. Stereotactic irradiation for intracranial arteriovenous malformation using stereotactic radiosurgery or hypofractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 2004; 60:861-70. [PMID: 15465204 DOI: 10.1016/j.ijrobp.2004.04.041] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2003] [Revised: 03/08/2004] [Accepted: 04/12/2004] [Indexed: 11/20/2022]
Abstract
PURPOSE To investigate the appropriateness of the treatment policy of stereotactic irradiation using both hypofractionated stereotactic radiotherapy (HSRT) and stereotactic radiosurgery (SRS) for arteriovenous malformations (AVMs) located in an eloquent region or for large AVMs and using SRS alone for the other AVMs. METHODS AND MATERIALS Included in this study were 75 AVMs in 72 patients, with a mean follow-up of 52 months. Of the 75 AVMs, 33 were located in eloquent regions or were >2.5 cm in maximal diameter and were given 25-35 Gy (mean, 32.4 Gy) in four daily fractions at a single isocenter if the patient agreed to prolonged wearing of the stereotactic frame for 5 days. The other 42 AVMs were treated with SRS at a dose of 15-25 Gy (mean, 24.1 Gy) at the isocenter. The 75 AVMs were classified according to the Spetzler-Martin grading system; 21, 23, 28, 2, and 1 AVM were Grade I, II, III, IV, V, and VI, respectively. RESULTS The overall actuarial rate of obliteration was 43% (95% confidence interval [CI], 30-56%) at 3 years, 72% (95% CI, 58-86%) at 5 years, and 78% (95% CI, 63-93%) at 6 years. The actuarial obliteration rate at 5 years was 79% for the 42 AVMs <2.0 cm and 66% for the 33 AVMs >2 cm. The 5- and 6-year actuarial obliteration rate was 61% (95% CI, 39-83%) and 71% (95% CI, 47-95%), respectively, after HSRT and 81% (95% CI, 66-96%) and 81% (95% CI, 66-96%), respectively, after SRS; the difference was not statistically significant. Radiation-induced necrosis was observed in 4 subjects in the SRS group and 1 subject in the HSRT group. Cyst formation occurred in 3 patients in the SRS group and no patient in the HSRT group. A permanent symptomatic complication was observed in 3 cases (4.2%), and 1 of the 3 was fatal. All 3 patients were in the SRS group. The annual intracranial hemorrhage rate was 5.5-5.6% for all patients. CONCLUSION Our treatment policy using SRS and HSRT was as effective as the policy involving SRS alone. The HSRT schedule was suggested to have a lower frequency of radiation necrosis and cyst formation than the high-dose SRS schedule. The benefit of HSRT compared with lower dose SRS has not yet been determined.
Collapse
Affiliation(s)
- Ta-Chen Chang
- Department of Radiology, School of Medicine, Hokkaido University Hospital, North-15 West-7, Sapporo 060-8638, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Aoyama H, Kamada K, Shirato H, Takeuchi F, Kuriki S, Iwasaki Y, Miyasaka K. Integration of functional brain information into stereotactic irradiation treatment planning using magnetoencephalography and magnetic resonance axonography. Int J Radiat Oncol Biol Phys 2004; 58:1177-83. [PMID: 15001262 DOI: 10.1016/j.ijrobp.2003.08.034] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2003] [Revised: 08/11/2003] [Accepted: 08/15/2003] [Indexed: 10/26/2022]
Abstract
PURPOSE To minimize the risk of neurologic deficit after stereotactic irradiation, functional brain information was integrated into treatment planning. METHODS AND MATERIALS Twenty-one magnetoencephalography and six magnetic resonance axonographic images were made in 20 patients to evaluate the sensorimotor cortex (n = 15 patients, including the corticospinal tract in 6), visual cortex (n = 4), and Wernicke's area (n = 2). One radiation oncologist was asked to formulate a treatment plan first without the functional images and then to modify the plan after seeing them. The pre- and postmodification values were compared for the volume of the functional area receiving > or =15 Gy and the volume of the planning target volume receiving > or =80% of the prescribed dose. RESULTS Of the 21 plans, 15 (71%) were modified after seeing the functional images. After modification, the volume receiving > or =15 Gy was significantly reduced compared with the values before modification in those 15 sets of plans (p = 0.03). No statistically significant difference was found in the volume of the planning target volume receiving > or =80% of the prescribed dose (p = 0.99). During follow-up, radiation-induced necrosis at the corticospinal tract caused a minor motor deficit in 1 patient for whom magnetic resonance axonography was not available in the treatment planning. No radiation-induced functional deficit was observed in the other patients. CONCLUSION Integration of magnetoencephalography and magnetic resonance axonography in treatment planning has the potential to reduce the risk of radiation-induced functional dysfunction without deterioration of the dose distribution in the target volume.
Collapse
Affiliation(s)
- Hidefumi Aoyama
- Department of Radiology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
| | | | | | | | | | | | | |
Collapse
|
48
|
Sidhu K, Cooper P, Ramani R, Schwartz M, Franssen E, Davey P. Delineation of brain metastases on CT images for planning radiosurgery: concerns regarding accuracy. Br J Radiol 2004; 77:39-42. [PMID: 14988136 DOI: 10.1259/bjr/68080920] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Conformal radiotherapy requires confidence that the images used for target delineation accurately reflect the pathological dimensions of the target. Radiosurgery, which is a conformal radiotherapy technique, is often used to treat brain metastases. The images of brain metastases can be affected by the method of image acquisition. A prospective study was undertaken to evaluate the effect of delay on CT images of brain metastases selected for radiosurgical treatment. A median delay from contrast administration of 65 min resulted in an increase in the volume of the metastases in 86% of cases when compared with the volumes of the same metastases determined from CT images acquired immediately following the administration of contrast medium. The magnitude of the increase in volume was sufficient to cause radiosurgery planners to select larger collimator sizes for radiosurgery plans based on the delayed CT images in 92% of cases. No significant intraobserver or interobserver variation was found in the group of radiosurgery planners. Differences in image acquisition may account in part for the differences in local control reported in the radiosurgical treatment of brain metastases.
Collapse
Affiliation(s)
- K Sidhu
- Department of Radiation Oncology, Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario M4N 3M5 Canada
| | | | | | | | | | | |
Collapse
|
49
|
Zhang XQ, Shirato H, Aoyama H, Ushikoshi S, Nishioka T, Zhang DZ, Miyasaka K. Clinical significance of 3D reconstruction of arteriovenous malformation using digital subtraction angiography and its modification with CT information in stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2003; 57:1392-9. [PMID: 14630278 DOI: 10.1016/s0360-3016(03)00780-6] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
PURPOSE A three-dimensional (3D) reconstruction method of arteriovenous malformation (AVM) nidus from digital subtraction angiography (DSA) in combination with CT and/or MRI was developed, and its usefulness was evaluated in this study. MATERIALS AND METHODS The contour of the AVM nidus was delineated on two orthogonal projected DSA images. First, the volume and center of the AVM nidus were calculated in a classic DSA plan using three maximal lengths of the nidus in three perpendicular directions, assuming that the nidus had a prolate ellipsoid shape. Second, in the 3D-DSA plan, the contours of the AVM nidus on the two orthogonal projected DSA images were segmented to be compatible with the slice thickness of the CT image. Assuming that each segment of the nidus has an ellipsoid pillar shape, the volume and center of each segment were calculated. The volume and 3D shape of the nidus were calculated by 3D reconstruction in the 3D-DSA plan. Third, in the CT-DSA plan, the contour based on the segmented DSA was superimposed on the corresponding transaxial CT image slice by slice. The cylindrical shape of the nidus in the transaxial image was modified using the enhanced CT images in the CT-DSA plan. These three planning methods were compared using dose-volume statistics from real patients' data. Eighteen patients with intracranial AVMs in different brain locations who had been treated by radiosurgery were the subjects of this study. To examine the visibility (validity) of the nidus on the CT image, the "nidus" was delineated on an enhanced CT image without DSA superposition in the CT plan and compared with the CT-DSA plan. RESULTS The variance in the distance between coordinates determined by the CT plan and those determined by the classic DSA plan was significantly larger than the variance in the CT-DSA plan (p < 0.0001 for lateral, AP, and craniocaudal directions). The difference in the variance was not reduced by the addition of MRI (p < 0.0001 for each direction). The mean volume +/- SD of the nidus calculated was 5.9 +/- 8.0 cm(3) in the classic DSA plan, 4.0 +/- 5.6 cm(3) in the 3D-DSA plan, and 3.6 +/- 5.2 cm(3) in the CT-DSA plan. The 3D-DSA plan significantly reduced the mean nidus volume 31.8% +/- 12.7% from the classic DSA plan (p = 0.0054). The CT-DSA plan further significantly reduced the volume 9.8% +/- 8.8% from the 3D-DSA plan (p = 0.0021). The mean overlapping volume of the nidus between the CT plan and CT-DSA plan was 2.6 +/- 4.3 cm(3) (range 0.17-18.9), corresponding to 63.7% +/- 19.2% (range 11.4-85.3%) of the volume in the CT-DSA plan. CONCLUSIONS The superposition of the segmented DSA information on CT was shown to be an important tool to determine the precise shape of the nidus and is suggested to be useful to reduce partial occlusion of the AVM or radiation complications in radiosurgery.
Collapse
Affiliation(s)
- Xiao-Qing Zhang
- Department of Radiotherapy, Shanghai Changhai Hospital, Shanghai, China
| | | | | | | | | | | | | |
Collapse
|
50
|
Emami B, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2003; 57:481-8. [PMID: 12957260 DOI: 10.1016/s0360-3016(03)00570-4] [Citation(s) in RCA: 94] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
PURPOSE To compare CT and MRI target volumes for nasopharyngeal carcinoma (NPC) and evaluate the role of intensity-modulated radiotherapy (IMRT) in treating composite CT+MRI targets. METHODS AND MATERIALS CT and T(1)/T(2)-weighted MRI scans were obtained for 8 consecutive NPC patients. Using CT, MRI, and fused CT/MRI, various target volumes (gross target volume, clinical target volume, and planning target volume [PTV]) and critical structures were outlined. For each patient, three treatment plans were developed: (1) a three-dimensional conformal RT (3D-CRT) plan using CT-based targets; (2) a 3D-CRT plan using composite CT+MRI targets; and (3) a IMRT plan using CT+MRI targets. The prescription dose was 57.6 Gy and 70.2 Gy to the initial and boost PTV, respectively. Treatment plans were compared using the PTV dose to 95% volume (D(95)), critical structure dose to 5% organ volume (D(5)), and mean dose. RESULTS Compared with CT, the MRI-based targets were 74% larger, more irregularly shaped, and did not always include the CT targets. For CT-based targets, 3D-CRT plans, in general, achieved adequate target coverage and sparing of critical structures. However, when these plans were evaluated using CT+MRI targets, the average PTV D(95) was approximately 60 Gy (14% underdosing), and critical structure doses were significantly worse. The use of IMRT for CT+MRI targets resulted in marked improvement in the PTV coverage and critical structure sparing: average PTV D(95) improved to 69.3 Gy, brainstem D(5) to <43 Gy (19% reduction), spinal cord D(5) to <37 Gy (19% reduction), and the mean dose to the parotids and cochlea reduced to below tolerance (23.7 Gy and 35.6 Gy, respectively). CONCLUSION CT/MRI fusion improved the determination of target volumes in NPC. In contrast to 3D-CRT, IMRT planning resulted in significantly improved coverage of composite CT+MRI targets and sparing of critical structures.
Collapse
Affiliation(s)
- Bahman Emami
- Department of Radiation Oncology, Loyola University Medical Center, Maywood, IL 60153, USA.
| | | | | |
Collapse
|